Analyzing Ratios: GeneDx Holdings Corp (WGS)’s Financial Story Unveiled

For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of GeneDx Holdings Corp (NASDAQ: WGS) closed at $68.43 in the last session, down -7.19% from day before closing price of $73.73. In other words, the price has decreased by -$7.19 from its previous closing price. On the day, 0.57 million shares were traded. WGS stock price reached its highest trading level at $74.41 during the session, while it also had its lowest trading level at $68.01.

Ratios:

We take a closer look at WGS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.27 and its Current Ratio is at 2.41. In the meantime, Its Debt-to-Equity ratio is 0.57 whereas as Long-Term Debt/Eq ratio is at 0.55.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on August 28, 2024, initiated with a Equal Weight rating and assigned the stock a target price of $34.

On July 10, 2024, Craig Hallum started tracking the stock assigning a Buy rating and target price of $43.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 15 ’24 when Stueland Katherine bought 45,415 shares for $70.02 per share.

ICAHN SCHOOL OF MEDICINE AT MO sold 865,800 shares of WGS for $64,935,000 on Oct 31 ’24. The 10% Owner now owns 2,866,833 shares after completing the transaction at $75.00 per share. On Oct 31 ’24, another insider, ICAHN SCHOOL OF MEDICINE AT MO, who serves as the 10% Owner of the company, bought 1,012,941 shares for $81.69 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, WGS now has a Market Capitalization of 1879867904 and an Enterprise Value of 1879508736. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.53 while its Price-to-Book (P/B) ratio in mrq is 9.18. Its current Enterprise Value per Revenue stands at 7.033 whereas that against EBITDA is -48.485.

Stock Price History:

Over the past 52 weeks, WGS has reached a high of $89.11, while it has fallen to a 52-week low of $1.16. The 50-Day Moving Average of the stock is 22.33%, while the 200-Day Moving Average is calculated to be 134.89%.

Shares Statistics:

According to the various share statistics, WGS traded on average about 558.29K shares per day over the past 3-months and 645800 shares per day over the past 10 days. A total of 25.98M shares are outstanding, with a floating share count of 21.35M. Insiders hold about 25.84% of the company’s shares, while institutions hold 66.98% stake in the company. Shares short for WGS as of 1730332800 were 2603772 with a Short Ratio of 4.66, compared to 1727654400 on 2205081. Therefore, it implies a Short% of Shares Outstanding of 2603772 and a Short% of Float of 24.95.

Most Popular